Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alfa-2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01708941
What this trial is testing

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+2 more
National Cancer Institute (NCI) 88
Large-scale testing (Phase 3)Study completedNCT01579474
What this trial is testing

Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

Who this might be right for
Hepatitis C
Boehringer Ingelheim 131
Large-scale testing (Phase 3)Active Not RecruitingNCT01274338
What this trial is testing

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Who this might be right for
Melanoma of Unknown PrimaryRecurrent MelanomaStage IIIB Cutaneous Melanoma AJCC v7+2 more
National Cancer Institute (NCI) 1,673
Large-scale testing (Phase 3)WithdrawnNCT01590225
What this trial is testing

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Ended earlyNCT00423800
What this trial is testing

Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 56
Large-scale testing (Phase 3)Study completedNCT01366638
What this trial is testing

TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 79
Testing effectiveness (Phase 2)Study completedNCT02155322
What this trial is testing

A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 33
Not applicableStudy completedNCT06752941
What this trial is testing

LOW-PV Continuation

Who this might be right for
Polycythemia Vera
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 36
Testing effectiveness (Phase 2)Study completedNCT00049530
What this trial is testing

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 32
Large-scale testing (Phase 3)Study completedNCT00529568
What this trial is testing

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 759
Large-scale testing (Phase 3)Study completedNCT01405560
What this trial is testing

Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 42
Not applicableEnded earlyNCT00856024
What this trial is testing

ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 902
Testing effectiveness (Phase 2)Study completedNCT00014092
What this trial is testing

Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery

Who this might be right for
Melanoma (Skin)
Saint Francis Hospital
Not applicableEnrolling By InvitationNCT06707922
What this trial is testing

A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 350
Testing effectiveness (Phase 2)Study completedNCT01658813
What this trial is testing

5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer

Who this might be right for
Gastrointestinal Cancer MetastaticRenal Cell Cancer MetastaticNon Small Cell Lung Cancer Metastatic
Western Regional Medical Center 18
Early research (Phase 1)Study completedNCT00253474
What this trial is testing

PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma

Who this might be right for
Neoplasm of Uncertain Malignant PotentialUnspecified Childhood Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 36
Large-scale testing (Phase 3)UnknownNCT00002763
What this trial is testing

High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 1,000
Large-scale testing (Phase 3)Study completedNCT00003444
What this trial is testing

Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 167
Testing effectiveness (Phase 2)Study completedNCT00055809
What this trial is testing

Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors

Who this might be right for
Metastatic Gastrointestinal Carcinoid TumorRecurrent Gastrointestinal Carcinoid TumorRegional Gastrointestinal Carcinoid Tumor
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT00006384
What this trial is testing

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
City of Hope Medical Center
Next Page